Efficacy and safety from a phase 2B trial of SM04690, a novel, intra-articular, WNT pathway inhibitor for the treatment of osteoarthritis of the knee. (April 2019) - Yazici, Y.; McAlindon, T.E.; Gibofsky, A.; Lane, N.E.; Latterman, C.; Skrepnik, N.; Swearingen, C.J.; DiFrancesco, A.; Tambiah, J.R.; Hochberg, M.C.